{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:14:38Z","timestamp":1780352078626,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.xops.2025.100706","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T02:52:04Z","timestamp":1736736724000},"page":"100706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-3019","authenticated-orcid":false,"given":"Shervonne","family":"Poleon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-5153","authenticated-orcid":false,"given":"Michael","family":"Twa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-7819","authenticated-orcid":false,"given":"Yu-Mei","family":"Schoenberger-Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Fifolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyne","family":"Racette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100706_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/eye.2012.294","article-title":"Patterns of adherence behaviour for patients with glaucoma","volume":"27","author":"Cate","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100706_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1089\/jop.2015.0102","article-title":"Quantifying glaucoma medication adherence: the relationship between self-report, electronic monitoring, and pharmacy refill","volume":"32","author":"Kumar","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100706_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9394(86)90939-6","article-title":"Compliance with topical pilocarpine treatment","volume":"101","author":"Kass","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Ann Rev Clin Psychol"},{"key":"10.1016\/j.xops.2025.100706_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Socio Methods Res"},{"key":"10.1016\/j.xops.2025.100706_bib9","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s11136-013-0380-2","article-title":"Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy","volume":"22","author":"Shi","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.xops.2025.100706_bib10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/PPA.S270809","article-title":"Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on angiotensin-converting enzyme inhibitors (ACEIs)\/Angiotensin receptor blockers (ARBs)","volume":"14","author":"Paranjpe","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.xops.2025.100706_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12028-016-0263-9","article-title":"Group-based trajectory modeling of suppression ratio after cardiac arrest","volume":"25","author":"Elmer","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.xops.2025.100706_bib12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xops.2025.100706_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archopht.122.11.1667","article-title":"Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study","volume":"122","author":"Siatkowski","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archophthalmol.2010.351","article-title":"Glaucoma medication adherence: room for improvement in both performance and measurement","volume":"129","author":"Muir","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0193945911427153","article-title":"Practical and analytic issues in the electronic assessment of adherence","volume":"34","author":"Cook","year":"2012","journal-title":"West J Nurs Res"},{"key":"10.1016\/j.xops.2025.100706_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xops.2025.100706_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/IJG.0000000000000205","article-title":"Characterization of glaucoma medication adherence in kaiser permanente southern California","volume":"25","author":"Jones","year":"2016","journal-title":"J Glaucoma"},{"key":"10.1016\/j.xops.2025.100706_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/neu.2012.2578","article-title":"Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example","volume":"30","author":"Niyonkuru","year":"2013","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.xops.2025.100706_bib20","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.xops.2025.100706_bib21","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ophtha.2010.03.040","article-title":"Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss","volume":"117","author":"Hennessy","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ophtha.2009.01.021","article-title":"Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma","volume":"116","author":"Friedman","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajo.2024.01.019","article-title":"Long-term effect of systemic comorbidity on glaucoma medication adherence","volume":"261","author":"Hou","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib24","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","article-title":"Determinants of medication adherence to topical glaucoma therapy","volume":"21","author":"Dreer","year":"2012","journal-title":"J Glaucoma"},{"key":"10.1016\/j.xops.2025.100706_bib26","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/IJG.0b013e3182741f1c","article-title":"Beliefs and adherence to glaucoma treatment: a comparison of patients from diverse cultures","volume":"23","author":"Rees","year":"2014","journal-title":"J Glaucoma"},{"key":"10.1016\/j.xops.2025.100706_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bjo.2010.199851","article-title":"Validation of a short version of the glaucoma medication self-efficacy questionnaire","volume":"96","author":"Sleath","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.xops.2025.100706_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1331\/JAPhA.2013.12065","article-title":"Medication adherence program: adherence challenges and interventions in type 2 diabetes","volume":"53","author":"Odegard","year":"2013","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.xops.2025.100706_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ophtha.2021.10.009","article-title":"The impact of the coronavirus disease 2019 pandemic on adherence to ocular hypotensive medication in patients with primary open-angle glaucoma","volume":"129","author":"Racette","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100706_bib32","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/eye.2010.27","article-title":"Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid","volume":"24","author":"Ajit","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100706_bib33","first-page":"109","article-title":"[Relationships among illness perceptions, medication beliefs and medication adherence in primary angle closure glaucoma patients]","volume":"53","author":"Jiang","year":"2017","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.xops.2025.100706_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40615-017-0350-4","article-title":"The effects of race and racial concordance on patient-physician communication: a systematic review of the literature","volume":"5","author":"Shen","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.xops.2025.100706_bib35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/IJG.0000000000001943","article-title":"Topical medication adherence and visual field progression in open-angle glaucoma: analysis of a large US health care system","volume":"30","author":"Shu","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.xops.2025.100706_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MLR.0b013e31818afa1c","article-title":"Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis","volume":"47","author":"Curtis","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.xops.2025.100706_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2415-12-57","article-title":"Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management","volume":"12","author":"Cate","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2025.100706_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40258-019-00497-0","article-title":"Using adherence-contingent rebates on chronic disease treatment costs to promote medication adherence: results from a randomized controlled trial","volume":"17","author":"Bilger","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.xops.2025.100706_bib39","article-title":"Interventions for improving adherence to ocular hypotensive therapy","volume":"2013","author":"Waterman","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2025.100706_bib40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/08870446.2015.1070851","article-title":"A systematic review and meta-analysis of the brief illness perception questionnaire","volume":"30","author":"Broadbent","year":"2015","journal-title":"Psychol Health"},{"key":"10.1016\/j.xops.2025.100706_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12160-012-9371-8","article-title":"Group-based trajectory modeling of caregiver psychological distress over time","volume":"44","author":"Choi","year":"2012","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.xops.2025.100706_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/02770903.2018.1424195","article-title":"Controller adherence following hospital discharge in high risk children: a pilot randomized trial of text message reminders","volume":"56","author":"Kenyon","year":"2019","journal-title":"J Asthma"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:47:11Z","timestamp":1772048831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2666914525000041"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100706","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100706"}}